Respmedicalsp. z o.o. in liquidation

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-18
Share capital
7,100.00 PLN
Registered address
ul. Związkowa 26, 20-148 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

  • 2025not filed
  • 202430/06/2025
  • 202326/06/2024
  • 202227/06/2023
  • 202130/06/2022
  • 202030/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Sanctions and PEP lists

PersonList
Tadeusz Piotr KościńskiMinister skarbu i finansów

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 3.77kMedianUSD 287.80kAverageUSD 4.91m
Net profit
This companyUSD -13.10kMedianUSD 12.59kAverageUSD 208.04k
Operating costs
This companyUSD 16.87kMedianUSD 272.78kAverageUSD 4.49m
Assets
This companyUSD 45.55kMedianUSD 224.38kAverageUSD 5.76m

Trademarks

Respmedical holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2020.

MarkNumberClassesStatusProtected until
Breather ONEZ.52154210Protected Dec 1, 2030
MarkProtected until
Breather ONEDec 1, 2030

Authorized Representatives

Piotr Marcin Kozłowski – Liquidator

Supervisory board

Kazimierz Agatowski – Supervisory Board Member
Anna Kozłowska – Supervisory Board Member
Łukasz Jan Gołąbek – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Rafał Paweł Agatowskiage 38
50$675.3135.2113%
Piotr Marcin Kozłowskiage 39
50$675.3135.2113%
42$567.2629.5775%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-06-01.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Aug 5, 2026Liquidation opened

Public aid

8 public aid cases recorded, with a total value of $295,228.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,285
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,947
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Change history

DateEvent
2026-06-22Liquidation opened
2020-04-03Share capital increase
2020-04-03PKD change
2019-03-18Entered in the register

FAQ

Last updated: 2026-10-03